PMID- 21701511 OWN - NLM STAT- MEDLINE DCOM- 20110824 LR - 20240210 IS - 1474-1768 (Electronic) IS - 1474-175X (Print) IS - 1474-175X (Linking) VI - 11 IP - 7 DP - 2011 Jun 24 TI - DNA interstrand crosslink repair and cancer. PG - 467-80 LID - 10.1038/nrc3088 [doi] AB - Interstrand crosslinks (ICLs) are highly toxic DNA lesions that prevent transcription and replication by inhibiting DNA strand separation. Agents that induce ICLs were one of the earliest, and are still the most widely used, forms of chemotherapeutic drug. Only recently, however, have we begun to understand how cells repair these lesions. Important insights have come from studies of individuals with Fanconi anaemia (FA), a rare genetic disorder that leads to ICL sensitivity. Understanding how the FA pathway links nucleases, helicases and other DNA-processing enzymes should lead to more targeted uses of ICL-inducing agents in cancer treatment and could provide novel insights into drug resistance. FAU - Deans, Andrew J AU - Deans AJ AD - London Research Institute, Cancer Research UK, Clare Hall Laboratories, South Mimms EN63LD, UK. FAU - West, Stephen C AU - West SC LA - eng GR - 11582/CRUK_/Cancer Research UK/United Kingdom GR - 249145/ERC_/European Research Council/International PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20110624 PL - England TA - Nat Rev Cancer JT - Nature reviews. Cancer JID - 101124168 RN - 0 (Antineoplastic Agents) RN - 0 (Cross-Linking Reagents) SB - IM MH - Animals MH - Antineoplastic Agents/*pharmacology MH - Cross-Linking Reagents/*pharmacology MH - DNA Damage MH - *DNA Repair MH - Drug Resistance, Neoplasm MH - Fanconi Anemia/genetics MH - Humans MH - Neoplasms/*drug therapy/etiology/genetics MH - Recombination, Genetic PMC - PMC3560328 MID - EMS51353 OID - NLM: EMS51353 EDAT- 2011/06/28 06:00 MHDA- 2011/08/25 06:00 PMCR- 2013/01/31 CRDT- 2011/06/25 06:00 PHST- 2011/06/25 06:00 [entrez] PHST- 2011/06/28 06:00 [pubmed] PHST- 2011/08/25 06:00 [medline] PHST- 2013/01/31 00:00 [pmc-release] AID - nrc3088 [pii] AID - 10.1038/nrc3088 [doi] PST - epublish SO - Nat Rev Cancer. 2011 Jun 24;11(7):467-80. doi: 10.1038/nrc3088.